Kampo medicines consist of a variety of crude animal, plant, and mineral extracts that have long been used to relieve different symptoms, and are relatively safe. However, their mechanisms of actions have not been well investigated. We screened 61 commercially available Kampo medicines to determine if they contain constituents with antifungal activity against Trichophyton rubrum. The antifungal effect of the Kampo medicines was determined by measuring the mean absorbance of treated fungal culture media. Lower absorbance values suggested a higher inhibition of the growth rate of T. rubrum by the Kampo medicines. We found that seven of the evaluated formulations exhibited a comparable antifungal activity to that of fluconazole at 14 mg/mL. The seven active Kampo medicines were Saiko-keishi-kankyou-to, Saiko-ka-ryukotsu-borei-to, Saiko-keishi-to, Keishi-ka-ryukotsu-borei-to, Dai-saiko-to, Bohu-tsu-sho-san, and Otsu-ji-to. The seven Kampo medicines with antifungal activity contain 30 different crude extracts, and Ou-gon (Scutellaria root) is a supplement contained in six of the seven formulations. Therefore, Ou-gon was considered to play a major role in their antifungal effect. The antifungal assay of the Ou-gon water extract showed that it significantly inhibited the growth of T. rubrum at a concentration of 20 mg/mL. Future studies will focus on the isolation and identification of the antifungal components of the crude extracts of Ou-gon, which may be potentially useful, new, and safe antifungal drugs.
CyongJC, KimSM, IijimaK, KobayashiT, FuruyaM. (2000) Clinical and pharmacological studies on liver disease treated with Kampo herbal medicine. The American Journal of Chinese Medicine, 28, 351–360.
2.
FuyunoI. (2011) Japan: Will the sun set on Kampo?Nature, 480, S96–S96.
3.
OkumiH, KoyamaA. (2014) Kampo medicine for palliative care in Japan. Biopsychosocial Medicine, 8, 6.
4.
SatohH. (2013) Pharmacological characteristics of Kampo medicine as a mixture of constituents and ingredients. Journal of Integrative Medicine, 11, 11–16.
5.
ZasloffM. (2002) Antimicrobial peptides of multicellular organisms. Nature, 415, 389–395.
6.
NishimuraK, PlotnikoffGA, WatanabeK, (2009) Kampo medicine as an integrative medicine in Japan. Japan Medical Association Journal, 52, 147–149.
7.
TakasunaK, KasaiY, KitanoY, MoriK, KobayashiR, HagiwaraT, KakihataK, HirohashiM, NomuraM, NagaiE, KamatakT. (1995) Protective effects of Kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats. Japan Journal of Cancer Research, 86, 978–984.
8.
YamadaH, SaikiI. (2005) Juzen-taiho-to (shi-quan-da-bu-tang): Scientific Evaluation and Clinical Applications. The Chemical Rubber Company Press, Florida.
9.
IwaseS, YamaguchiT, MiyajiT, TerawakiK., InuiA, UezonoY. (2012) The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients' symptoms in Japan: a national cross-sectional survey. BMC Complementary and Alternative Medicine, 12, 222.
10.
AbeS, TanshoS, IshibashiH, InagakiN, KomatsuY, YamaguchiH. (1998) Protective effect of oral administration of a traditional medicine, Juzen-Taiho-To, and its components on lethal Candida albicans infection in immunosuppressed mice. Immunopharmacology and Immunotoxicology, 20, 421–431.
11.
AbeS, IshibashiH, TanshoS, HanazaraR, KomatsuY, YamaguchiH. (1999) Protective effect of oral administration of several traditional Kampo-medicines on lethal Candida infection in immunosuppressed mice. Nihon Ishinkin Gakkai Zasshi, 41, 115–119.
12.
HigakiS, NorisugiO, ToyomotoT. (2005) Representative species, skin diseases and Kampo medicines (chemical & pharmacological study). Journal of Traditional Medicines, 22, 167–170.
13.
NishikataN, NakamoriK, SueyoshiM, TakahasiH, YujiH, SanoA. (2010) [Evaluation of antifungal effects of a traditional medicine containing 17 components on Trichophyton verrucosum and Malassezia pachydermatis by microdilution]. Medical Mycology Journal, 52, 213–221.
14.
KobayashiY, HuangX, TakasugiM, ChibaK, KatoT, ShirahataT, InoC. (2014) Antimicrobial effects on Porphyromonas gingivalis by KAMPO (traditional Japanese herbal medicine) formulas containing Rhei rhizoma, and its active components. Planta Medica, 80, P1C7.
15.
ZauggC, MonodM, WeberJ, HarshmanK, PradervandS, ThomasJ, BuenoM, GiddeyK, StaibP. (2009) Gene expression profiling in the human pathogenic dermatophyte Trichophyton rubrum during growth on proteins. Eukaryotic Cell, 8, 241–250.
16.
AmichaiB, GrunwaldMH, (1998) Adverse drug reactions of the new oral antifungal agents-terbinafine, fluconazole, and itraconazole. International Journal of Dermatology, 37, 410–415.
17.
KhanMS, AhmadI. (2011) Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum.Applied Microbiology and Biotechnology, 90, 1083–1094.
18.
NishiokaT, KawabataJ, AoyamaY. (1998). Baicalein, an alpha-glucosidase inhibitor from Scutellaria baicalensis. Journal of Natural Products, 61, 1413–1415.
19.
HirotaniM, KurodaR, SuzukiH, YoshikawaT. (2000) Cloning and expression of UDP-glucose: flavonoid 7-O-glucosyltransferase from hairy root cultures of Scutellaria baicalensis.Planta, 210, 1006–1013.
20.
WongKS, TsangWK. (2009) In vitro antifungal activity of the aqueous extract of Scutellaria baicalensis Georgi root against Candida albicans. International Journal of Antimicrobial Agents, 34, 284–285.
21.
ShiGX, ShaoJ, WangTM, WangCZ. (2014) [New advance in studies on antimicrobial activity of Scutellaria baicalensis and its effective ingredients]. Zhongguo Zhong Yao Za Zhi, 39, 3713–3718.
22.
TomimoriT, JinH, MiyaichiY, ToyofukuS, NambaT. (1985) Studies on the constituents of Scutellaria species. VI. On the flavonoid constituents of the root of Scutellaria baicalensis Georgi (5). Quantitative analysis of flavonoids in Scutellaria roots by high-performance liquid chromatography. Yakugaku Zasshi, 105, 148–155.
23.
CaoY, DaiB, WangY, HuangS, XuY, CaoY, GaoP, ZhuZ, JiangY. (2008) In vitro activity of baicalein against Candida albicans biofilms. International Journal of Antimicrobial Agents, 32, 73–77.
24.
KangK, FongWP, TsangPW. (2010) Antifungal activity of baicalein against Candida krusei does not involve apoptosis. Mycopathologia, 170, 391–396.
25.
YangS, FuY, WuX, ZhouZ, XuJ, ZengX, KuangN, ZengY. (2014) Baicalin prevents Candida albicans infections via increasing its apoptosis rate. Biochemical and Biophysical Research Communications, 451, 36–41.
BroekaertWF, TerrasFR, CammueBP, Van der leydenJ. (1990) An automated quantitative assay for fungal growth inhibition. FEMS Microbiology Letters, 69, 55–59.
28.
YamashitaY, OkazakiK. (2004) Purification and antifungal activity of recombinant chitinase from Escherichia coli carrying the family 19 chitinase gene of Streptomyces sp. J-13-3. Bioscience Biotechnology Biochemistry, 68, 2193–2196.
29.
HayashiMA, BizerraFC, Da SilvaPI.Jr (2013) Antimicrobial compounds from natural sources. Frontiers in Microbiology, 4, 195.
30.
HeinKZ, TakahashiH, TsumoriT, YasuiY, NanjohY, TogaT, WuZ, GrötzingerJ, JungS, WehkampJ, SchroederBO, SchroederJM, MoritaE. (2015) Disulphide-reduced psoriasin is a human apoptosis-inducing broad-spectrum fungicide. Proceedings of the National Academy of Sciences of the United States of America, 112, 13039–13044.
